| Levels of Trimethylamine Metabolites and Their Associations with Dietary Intakes and Cardiometabolic Biomarkers: the TMAO Pooling Project |
Danxia Yu |
Vanderbilt University Medical Center |
PLCO |
Nov 2, 2018 |
PLCO-414 |
| Predictors of second primary cancers among patients diagnosed with lung cancer in the PLCO trial |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Nov 2, 2018 |
PLCO-417 |
| Lung Cancer Risk Prediction Modelling -- Extensions to the PLCOm2012 model |
Martin Carl Tammemagi |
Brock University |
PLCO |
Oct 26, 2018 |
PLCO-416 |
| Clinical Cancer Data Analysis |
Canan Eren |
New Jersey Institute of Technology |
PLCO |
Oct 26, 2018 |
PLCO-410 |
| Serum Metabolomic Profiling of Glioma Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Jiaqi Huang |
NIH |
PLCO |
Oct 23, 2018 |
2017-1017 |
| Physical activity, PSA levels, and screen-detected prostate cancers. |
Yelena Tarasenko |
Georgia Southern University |
PLCO |
Oct 23, 2018 |
PLCO-415 |
| The use of data from Food Frequency Questionnaire (FFQ) for network analysis on cancer survivorship and food intake |
Linghan Qian |
Tufts University |
PLCO |
Oct 15, 2018 |
PLCO-405 |
| Monitoring with Repeatedly Measured Markers: Application to longitudinal PSA measurements in PLCO |
Paramita Saha-Chaudhuri |
McGill University |
PLCO |
Oct 12, 2018 |
PLCO-408 |
| Impact of colorectal cancer sidedness on the outcomes of colorectal cancer patients diagnosed within PLCO study |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Oct 12, 2018 |
PLCO-407 |
| Diabetes and Cancer Initiative |
Marc Gunter |
International Agency for Research on Cancer |
PLCO |
Oct 11, 2018 |
PLCO-397 |
| Hormonal factors and risk of lung cancer: Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and a meta-analysis of 10 cohort studies |
Zuo-Feng Zhang |
Fielding School of Public Health, University of California, Los Angeles, CA, USA |
PLCO |
Oct 11, 2018 |
PLCO-406 |
| Modification of the Associations Between Aspirin Use and Colorectal, Ovarian, Endometrial, Breast, and Prostate Cancer Risk |
Lauren Hurwitz |
National Cancer Institute |
PLCO |
Oct 4, 2018 |
PLCO-403 |
| Interaction of Calcium Intake and Obesity on Pancreatic Cancer in the PLCO Trial |
Margaret Hoyt |
Indiana University |
PLCO |
Oct 4, 2018 |
PLCO-404 |
| Design and validation of an oral cancer risk prediction model |
Anil Chaturvedi |
National Cancer Institute |
PLCO |
Sep 28, 2018 |
PLCO-402 |
| Performance Evaluation of Colorectal Cancer Diagnosis Classification using Machine Learning Algorithms. |
HYUNJIN KWON |
Open Convergence Lab |
PLCO |
Sep 28, 2018 |
PLCO-399 |
| Interaction of family history, physical activity and environmental factors in the risk for the development of prostate cancer |
Omar Abdel-Rahman |
Avicenna Oncology Center |
PLCO |
Sep 25, 2018 |
PLCO-398 |
| Baseline PSA and Risk of Prostate Cancer Diagnosis |
Amanda Black |
NCI |
PLCO |
Sep 12, 2018 |
PLCO-400 |
| Time to Event Prediction Based on Risk Calculation from Biomarkers |
Anna Lokshin |
University of Pittsburgh |
PLCO |
Sep 4, 2018 |
PLCO-395 |
| Chest-Xray Image Analysis |
Hayit Greenspan |
RadLogics |
PLCO |
Sep 4, 2018 |
PLCO-396 |
| PSA and CA125 in relation to epidemiologic, serologic, and genetic data and cancer risk in PLCO |
Michael Cook |
NCI |
PLCO |
Aug 23, 2018 |
PLCO-394 |
